Loading insider details...
Beta
Latest Form 4 (Jun 4, 2026): Grant/Award of 7,490 BMRN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,490 | n/a |
| May 11, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 1,438 | $255.4K |
| Jun 4, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 946 | $127.7K |
| May 22, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 6,650 | n/a |
| May 23, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 4,720 | n/a |
| Feb 12, 2024 | ImmunoGen, Inc. (IMGN) | Disposition to Issuer | 584,397 | n/a |
| Feb 6, 2024 | ImmunoGen, Inc. (IMGN) | Exercise/Conversion | 51,234 | n/a |
| Feb 5, 2024 | ImmunoGen, Inc. (IMGN) | Grant/Award | 140,357 | n/a |
| Dec 28, 2023 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 2,180 | n/a |
| Jun 9, 2020 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 13,700 | n/a |